Original from: Medix Biochemica
Medix Biochemica, a global leader in the supply of critical raw materials for the in vitro diagnostics (IVD) industry, announced the acquisition of CANDOR Bioscience GmbH, a Germany-based developer and manufacturer of premium immunoassay solutions. The acquisition both strengthens Medix Biochemica¡¯s range of high-quality raw materials to the worldwide IVD industry and enhances its capabilities to support test manufacturers in immunoassay development. Following the transaction, CANDOR Bioscience¡¯s high-quality operations will remain in Wangen im Allgäu, Germany.
CANDOR Bioscience, founded in 2004 by Dr Tobias Polifke and Dr Peter Rauch, is a German provider of a comprehensive selection of premium solutions for immunoassays, including HAMA and interference blockers, surface blockers, stabilizers and buffer solutions. By using CANDOR Bioscience¡¯s solutions, immunoassay manufacturers can improve reliability of test results, simplify assay designs and reduce process times.
¡°We are delighted to welcome CANDOR into the Medix Biochemica family. The partnership with CANDOR strengthens Medix Biochemica¡¯s ability to support our customer base by adding complementary expertise in immunoassay development and broadening our offering of critical IVD raw materials with a leading portfolio of premium blockers and stabilizers. Together, we will continue to provide the highest quality raw materials that enable diagnostic innovation, and we look forward to a successful collaboration with the CANDOR team,¡± says Steve Ferguson, CEO of Medix Biochemica.
Dr Tobias Polifke and Dr Peter Rauch, co-founders and Managing Directors of CANDOR Bioscience, are excited about the partnership: ¡°Joining forces with Medix Biochemica is an exciting milestone for CANDOR. We are proud of our legacy in providing differentiated, high-performance solutions for immunoassay development, and we share Medix Biochemica¡¯s commitment to quality and innovation. By combining our capabilities and offerings, we will be better positioned to support the evolving needs of our customers. Medix Biochemica¡¯s products, including antibodies and quality control materials, perfectly complement our solutions, enhancing the value we offer to partners in the IVD industry¡±.
